Jain Global’s Sionna Therapeutics SION Stock Holding History

Jain Global’s Portfolio SION Stock Details SION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,513	Closed	-$250K	–	1592
2025 Q3	$250K	Buy	+8,513	New	+$185K	﹤0.01%	849

Other funds holding SION

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jain Global's SION Position: Q4 2025 in Review

Jain Global sold out of Sionna Therapeutics (SION) in Q4 2025, closing a stake of 8,513 shares — an estimated $250K sold.

Jain Global first reported a position in SION in Q3 2025 and held it in 1 quarter. The position peaked at $250K in Q3 2025. 101 funds tracked by Wall St. Rank hold SION as of Q4 2025.

Jain Global reported no remaining Sionna Therapeutics position as of Q4 2025 after selling out during the quarter.
Jain Global sold 8,513 Sionna Therapeutics shares in Q4 2025, an estimated $250K.
Jain Global first reported a position in Sionna Therapeutics in Q3 2025 and held it in 1 quarter.
Jain Global's Sionna Therapeutics position peaked at $250K in Q3 2025.
101 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.